tradingkey.logo

Select Medical Holdings Corp

SEM
14.770USD
-0.070-0.47%
收盘 12/26, 16:00美东报价延迟15分钟
1.83B总市值
16.90市盈率 TTM

Select Medical Holdings Corp

14.770
-0.070-0.47%

关于 Select Medical Holdings Corp 公司

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics in 39 states and the District of Columbia.

Select Medical Holdings Corp简介

公司代码SEM
公司名称Select Medical Holdings Corp
上市日期Sep 25, 2009
CEOMullin (Thomas P)
员工数量30000
证券类型Ordinary Share
年结日Sep 25
公司地址C/O Select Medical Corp
城市MECHANICSBURG
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编17055
电话17179721100
网址https://www.selectmedical.com/
公司代码SEM
上市日期Sep 25, 2009
CEOMullin (Thomas P)

Select Medical Holdings Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%
Mr. Michael F. Malatesta
Mr. Michael F. Malatesta
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
238.06K
-3.00%
Mr. Thomas A. (Tom) Scully, J.D.
Mr. Thomas A. (Tom) Scully, J.D.
Independent Director
Independent Director
89.39K
+12.60%
Dr. Parvinderjit Singh Khanuja
Dr. Parvinderjit Singh Khanuja
Independent Director
Independent Director
79.12K
+21.56%
Ms. Katherine R. Davisson
Ms. Katherine R. Davisson
Independent Director
Independent Director
60.03K
+30.51%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
9.93M
+7.96%
Mr. Martin F. Jackson
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance and Operations
Senior Executive Vice President of Strategic Finance and Operations
1.38M
-0.76%
Mr. David S. Chernow
Mr. David S. Chernow
Vice Chairman of the Board
Vice Chairman of the Board
892.83K
-5.21%
Mr. Russell L. Carson
Mr. Russell L. Carson
Lead Independent Director
Lead Independent Director
610.03K
+2.35%
Mr. Thomas P. (Tom) Mullin
Mr. Thomas P. (Tom) Mullin
Chief Executive Officer
Chief Executive Officer
391.71K
-5.33%
Mr. Brian R. Rusignuolo
Mr. Brian R. Rusignuolo
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
361.37K
-3.90%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Non-Medicar
826.30M
61.68%
Medicare
381.56M
28.48%
Other
97.08M
7.25%
Other revenues
34.64M
2.59%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
其他
51.93%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.96%
T. Rowe Price Associates, Inc.
12.75%
The Vanguard Group, Inc.
10.13%
Ortenzio (Robert A)
8.02%
Dimensional Fund Advisors, L.P.
4.20%
其他
51.93%
股东类型
持股股东
占比
Investment Advisor
52.57%
Investment Advisor/Hedge Fund
18.21%
Individual Investor
16.10%
Hedge Fund
7.29%
Research Firm
2.78%
Pension Fund
1.25%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.19%
Insurance Company
0.03%
其他
1.04%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
584
101.41M
81.89%
-13.28M
2025Q2
593
128.59M
103.28%
-15.30M
2025Q1
613
130.41M
101.46%
-13.79M
2024Q4
596
127.65M
98.98%
-7.70M
2024Q3
574
125.33M
96.47%
-2.82M
2024Q2
559
125.84M
96.80%
-1.37M
2024Q1
555
124.62M
97.09%
-1.67M
2023Q4
554
125.18M
97.72%
-2.54M
2023Q3
563
124.92M
98.22%
-6.02M
2023Q2
572
126.44M
99.43%
-8.51M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
15.99M
12.9%
-497.15K
-3.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
16.02M
12.92%
-1.05M
-6.17%
Jun 30, 2025
The Vanguard Group, Inc.
12.90M
10.4%
-377.96K
-2.85%
Jun 30, 2025
Ortenzio (Robert A)
9.20M
7.42%
+250.00K
+2.79%
Jul 29, 2025
Dimensional Fund Advisors, L.P.
4.99M
4.02%
+773.73K
+18.35%
Jun 30, 2025
State Street Investment Management (US)
4.25M
3.43%
+55.69K
+1.33%
Jun 30, 2025
Rocco A. Ortenzio UEO
4.09M
3.3%
-3.80M
-48.22%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.04M
2.45%
+80.42K
+2.72%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.60M
2.9%
-429.17K
-10.65%
Jun 30, 2025
Principal Global Investors (Equity)
2.92M
2.36%
+447.99K
+18.09%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Services ETF
2.26%
Invesco S&P SmallCap Value with Momentum ETF
0.98%
Invesco S&P SmallCap Health Care ETF
0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
0.77%
First Trust Small Cap Value AlphaDEX Fund
0.71%
WisdomTree US SmallCap Quality Dividend Growth
0.71%
Invesco S&P SmallCap 600 Pure Value ETF
0.66%
Invesco S&P SmallCap 600 Revenue ETF
0.52%
Invesco Zacks Multi-Asset Income ETF
0.42%
Invesco S&P SmallCap Quality ETF
0.42%
查看更多
State Street SPDR S&P Health Care Services ETF
占比2.26%
Invesco S&P SmallCap Value with Momentum ETF
占比0.98%
Invesco S&P SmallCap Health Care ETF
占比0.94%
Invesco S&P SmallCap High Dividend Low Volatility ETF
占比0.77%
First Trust Small Cap Value AlphaDEX Fund
占比0.71%
WisdomTree US SmallCap Quality Dividend Growth
占比0.71%
Invesco S&P SmallCap 600 Pure Value ETF
占比0.66%
Invesco S&P SmallCap 600 Revenue ETF
占比0.52%
Invesco Zacks Multi-Asset Income ETF
占比0.42%
Invesco S&P SmallCap Quality ETF
占比0.42%

分红派息

近5年累计派现 243.71M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Oct 30, 2025
SEM.NB Final Cash Dividend of gross USD 0.0625 paid on Nov 25, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 25, 2025
Nov 12, 2025
Jul 31, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 28, 2025
Aug 13, 2025
May 01, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 15, 2025
May 15, 2025
May 29, 2025
May 15, 2025
Feb 20, 2025
SEM.NB Interim Cash Dividend of gross USD 0.0625 paid on Mar 13, 2025 going ex on Mar 03, 2025
Mar 03, 2025
Mar 13, 2025
Mar 03, 2025
Oct 31, 2024
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 26, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 26, 2024
Nov 13, 2024
Aug 01, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Aug 30, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 30, 2024
Aug 14, 2024
May 02, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on May 30, 2024 going ex on May 15, 2024
May 16, 2024
May 30, 2024
May 15, 2024
Feb 22, 2024
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Mar 13, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 13, 2024
Feb 29, 2024
Nov 02, 2023
SEM.NB Final Cash Dividend of gross USD 0.125 paid on Nov 28, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Nov 28, 2023
Nov 14, 2023
Aug 03, 2023
SEM.NB Interim Cash Dividend of gross USD 0.125 paid on Sep 01, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 01, 2023
Aug 14, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Select Medical Holdings Corp的前五大股东是谁?

Select Medical Holdings Corp 的前五大股东如下:
BlackRock Institutional Trust Company, N.A.持有股份:15.99M,占总股份比例:12.90%。
T. Rowe Price Associates, Inc.持有股份:16.02M,占总股份比例:12.92%。
The Vanguard Group, Inc.持有股份:12.90M,占总股份比例:10.40%。
Ortenzio (Robert A)持有股份:9.20M,占总股份比例:7.42%。
Dimensional Fund Advisors, L.P.持有股份:4.99M,占总股份比例:4.02%。

Select Medical Holdings Corp的前三大股东类型是什么?

Select Medical Holdings Corp 的前三大股东类型分别是:
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.

有多少机构持有Select Medical Holdings Corp(SEM)的股份?

截至2025Q3,共有584家机构持有Select Medical Holdings Corp的股份,合计持有的股份价值约为101.41M,占公司总股份的81.89%。与2025Q2相比,机构持股有所增加,增幅为-21.39%。

哪个业务部门对Select Medical Holdings Corp的收入贡献最大?

在FY2025Q2,Non-Medicar业务部门对Select Medical Holdings Corp的收入贡献最大,创收826.30M,占总收入的61.68%。
KeyAI